Skip to content

Author: Ben Shaberman

MeiraGTx Treats First Patient in XLRP Gene-Therapy Trial

Source: Foundation Fighting Blindness Blog – Eye on the Cure – MeiraGTx Treats First Patient in XLRP Gene-Therapy Trial MeiraGTx, a gene-therapy company in London and New York City, has treated its first patient in a gene-therapy clinical trial for people with X-linked retinitis pigmentosa (XLRP) caused by mutations…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Scientists Receive $25 Million to Develop a Vision-Restoring System that Connects to the Brain

Source: Foundation Fighting Blindness Blog – Eye on the Cure – Scientists Receive Million to Develop a Vision-Restoring System that Connects to the Brain Labels in English are (clockwise from upper left): Intelligent neuromorphic camera/LED; Matrix for optical stimulation of neurons/electronic; Implant for data processing/external; Antenna for energy transfer…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Foundation Fighting Blindness and 4D Molecular Therapeutics Partner to Boost Retinal Gene Therapy Development

Source: Foundation Fighting Blindness Blog – Eye on the Cure – Foundation Fighting Blindness and 4D Molecular Therapeutics Partner to Boost Retinal Gene Therapy Development Promising gene therapies for inherited retinal diseases (IRDs) — many of which have moved into clinical trials — use viral delivery systems (aka vectors)…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

FFB-Funded Scientists Report on Nine Promising Translational Research Efforts

Source: Foundation Fighting Blindness Blog – Eye on the Cure – FFB-Funded Scientists Report on Nine Promising Translational Research Efforts Translational research — moving promising science out of laboratories and into clinical trials — is essential to getting vision-saving, retinal-disease treatments out to the millions who need them. With…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Twelve People Receive XLRS Gene Therapy in AGTC’s Clinical Trial

Source: Foundation Fighting Blindness Blog – Eye on the Cure – Twelve People Receive XLRS Gene Therapy in AGTC’s Clinical Trial Applied Genetics Technology Corporation (AGTC) reported that its gene therapy for X-linked retinoschisis (XLRS) has performed encouragingly in a Phase I/II, safety-oriented clinical trial taking place at seven…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest